Comprehensive care – long COVID and diseases of ageing
NAD+ supplementation is a promising treatment strategy for age-associated metabolic decline and several age-related diseases
Learning objectives
- An awareness of the current understanding of long COVID pathophysiology and novel therapeutic approaches
- An understanding of the rationale of long COVID immunotherapy targeting the kynurenine pathway of NAD+ synthesis
- An understanding of the association between NAD+ depletion and the development of age-associated metabolic decline and several age-related diseases
- An awareness of how to optimise outcomes of NAD+ therapeutics.
To access this module, please register or login: